Recombinant Human MMP12 Protein, N-His

Introduction:
Recombinant Human MMP12 protein, also known as Matrix Metalloproteinase 12, is a member of the matrix metalloproteinase family. It is a zinc-dependent endopeptidase that plays a crucial role in the degradation and remodeling of extracellular matrix (ECM) components. This protein is expressed by various cell types, including macrophages, fibroblasts, and smooth muscle cells. Recombinant Human MMP12 protein is widely used in research and has potential therapeutic applications in various diseases. In this article, we will discuss the structure, activity, and applications of Recombinant Human MMP12 protein.

Structure of Recombinant Human MMP12 Protein:
The gene for MMP12 is located on chromosome 11q22.3 and consists of 11 exons. The mature form of the protein is composed of 471 amino acids and has a molecular weight of approximately 54 kDa. It contains a signal peptide, a propeptide, a catalytic domain, a hinge region, and a hemopexin-like domain. The catalytic domain contains a zinc-binding motif, which is essential for its proteolytic activity. The hemopexin-like domain is responsible for substrate recognition and binding.

Activity of Recombinant Human MMP12 Protein:
Recombinant Human MMP12 protein is a potent protease that is involved in the degradation of various ECM components, including collagen, elastin, and proteoglycans. It is activated by the removal of the propeptide by other proteases or by oxidative stress. Once activated, it can cleave a wide range of substrates, leading to tissue remodeling and repair. MMP12 is also involved in the activation of other MMPs, such as MMP-2 and MMP-9, which further contribute to ECM degradation.

Applications of Recombinant Human MMP12 Protein:
1. Research:
Recombinant Human MMP12 protein is widely used in research to study its role in various diseases, such as cancer, atherosclerosis, and pulmonary diseases. It is also used to investigate its interaction with other proteins and its regulation in different cell types. The availability of recombinant protein has made it easier to study the specific functions of MMP12 and its potential as a therapeutic target.

2. Therapeutic Applications:
MMP12 has been implicated in various diseases, making it a potential therapeutic target. In cancer, MMP12 is involved in tumor growth, invasion, and metastasis. Inhibiting MMP12 activity can reduce tumor growth and metastasis. In atherosclerosis, MMP12 is thought to contribute to plaque rupture, leading to heart attacks and strokes. Inhibiting MMP12 activity can prevent plaque rupture and reduce the risk of cardiovascular events. In pulmonary diseases, MMP12 has been linked to the development of emphysema. Inhibiting MMP12 can slow down the progression of emphysema and improve lung function.

3. Diagnostic Applications:
MMP12 has been proposed as a potential biomarker for various diseases. Its increased expression has been observed in cancer, atherosclerosis, and pulmonary diseases. Measuring MMP12 levels in biological fluids can aid in the diagnosis and monitoring of these diseases.

4. Production of Antibodies:
Recombinant Human MMP12 protein can be used to produce antibodies for research and diagnostic purposes. These antibodies can be used to detect the presence of MMP12 in tissues and biological fluids, and to study its expression and activity in different diseases.

Conclusion:
Recombinant Human MMP12 protein is a crucial enzyme involved in the degradation and remodeling of ECM components. Its structure, activity, and potential therapeutic applications make it a valuable tool in research and a potential target for various diseases. The availability of recombinant protein has facilitated the study of MMP12 and its potential as a diagnostic and therapeutic target. Further research on this protein may lead to the development of novel treatments for various diseases.